Clincosm LogoSign in Get a demo

angiosarcoma

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

Recruiting
  • Soft Tissue Sarcoma Adult
  • +2 more
  • Aarhus, Denmark
  • +3 more
Jul 23, 2023

Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +18 more
  • Basking Ridge, New Jersey
  • +6 more
May 18, 2023

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

Active, not recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Nov 6, 2022

Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

Recruiting
  • Advanced Cancer
  • +7 more
  • Scottsdale, Arizona
  • +14 more
Sep 15, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

Recruiting
  • Bone Sarcoma
  • +6 more
  • Treatment by Regorafenib
  • Treatment by Placebo
  • Besançon, France
  • +15 more
Aug 18, 2022

Angiosarcoma Trial in Austria, Germany (Pazopanib + Paclitaxel)

Terminated
Has Results
  • Angiosarcoma
  • Pazopanib + Paclitaxel
  • Graz, Austria
  • +9 more
Jan 21, 2022

Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

Recruiting
  • Angiosarcoma
  • Epithelioid Hemangioendothelioma
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Angiosarcoma Trial (AGEN2034, AGEN1884)

Withdrawn
  • Angiosarcoma
  • (no location specified)
Dec 21, 2021

Angiosarcoma Trial in Amsterdam (Propranolol)

Recruiting
  • Angiosarcoma
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek
Dec 20, 2021

Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

Withdrawn
  • Soft Tissue Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Nov 30, 2021

Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

Withdrawn
  • Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Jul 26, 2021

Congenital Hemangioma, Hemangioendothelioma, Angiosarcoma Trial in Gurgaon, Vellore (Lipiodol® Ultra Fluid with surgical glues)

Unknown status
  • Congenital Hemangioma
  • +3 more
  • Lipiodol® Ultra Fluid with surgical glues
  • Gurgaon, Haryana, India
  • +1 more
Feb 18, 2020

Angiosarcoma Trial in France (Paclitaxel, Bevacizumab)

Completed
  • Angiosarcoma
  • Bordeaux, France
  • +12 more
May 29, 2019

Angiosarcoma Trial in France (blood and urine, Questionnaire, Telephone interview)

Unknown status
  • Angiosarcoma
  • blood and urine
  • +2 more
  • Bordeaux, France
  • +11 more
Jul 28, 2016

Angiosarcoma Trial in Marseill (PROPRANOLOL)

Unknown status
  • Angiosarcoma
  • Marseill, France
    Assistance Publique Hôpitaux de Marseille
Apr 8, 2016

Sarcoma, Leiomyosarcoma, Malignant Fibrous Trial in New York (gemcitabine, docetaxel, bevacizumab)

Completed
Has Results
  • Sarcoma
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 21, 2015